SCHEMBL5777505

SCHEMBL5777505

c1ncn(-c2nc(NCCc3ccc4c(c3)OCO4)c3c4c(sc3n2)CCCC4)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 5/20 0.43
LMNA P02545 4/20 0.43
ALOX15 P16050 3/20 0.43
USP2 O75604 2/20 0.43
HTT P42858 7/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
MAPT P10636 7/20 0.42
HSD17B10 Q99714 4/20 0.42
HPGD P15428 4/20 0.42
GAA P10253 3/20 0.42
MAPK1 P28482 3/20 0.42
GLA P06280 2/20 0.42
ATM Q13315 2/20 0.42
TSHR P16473 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
POLB P06746 1/20 0.42
RAD52 P43351 1/20 0.42
PAX8 Q06710 1/20 0.42
PTPN12 Q05209 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5777372 0.92 PTPN12 (0.45) ALDH1A1KDM4ELMNAALOX15USP2
SCHEMBL5781513 0.87 ALDH1A1 (0.44) ALDH1A1KDM4ELMNAALOX15USP2
SCHEMBL5782312 0.86 HTT (0.45) ALDH1A1KDM4ELMNAALOX15USP2
SCHEMBL5798539 0.86 NOS2 (0.49) ALDH1A1KDM4ELMNAALOX15USP2
SCHEMBL5128666 0.85 BCDIN3D (0.42) ALDH1A1KDM4ELMNAHTTSMN1; SMN2
SCHEMBL5124141 0.83 BCDIN3D (0.41) ALDH1A1KDM4ELMNAALOX15USP2
SCHEMBL5124266 0.83 BCDIN3D (0.42) ALDH1A1ALOX15USP2HTTMAPT
SCHEMBL5779219 0.81 HTT (0.48) ALDH1A1KDM4ELMNAALOX15USP2
SCHEMBL5122859 0.81 BCDIN3D (0.43) ALDH1A1KDM4ESMN1; SMN2MAPTHSD17B10
SCHEMBL5122862 0.81 BCDIN3D (0.45) ALDH1A1KDM4EALOX15USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685136-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2006-08-02 EP disclosed
WO-2005047292-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2005-05-26 WO disclosed
US-6432950-B1 ANTICANCER AGENTS; KILLING CANCER CELLS CELL PATHWAYS 2002-08-13 US disclosed
US-6133271-A Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 2000-10-17 US disclosed
US-6110920-A TREATMENT OF CARDIOVASCULAR DISORDERS AND IMPOTENCY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-29 US disclosed
EP-0920431-A1 THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 1999-06-09 EP disclosed
WO-1998006722-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1998-02-19 WO disclosed